BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Clinical trial NCT04982393 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04982393
- Sponsor
- Alnylam Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-13
- Primary completion
- 2028-09-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.